(in millions $) | 1 May 2025 | 31 Jan 2025 | 31 Aug 2024 | 30 May 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $155.15 | $133.77 | ||
Inventory | ||||
Total current assets | $1021.28 | $1065.94 | ||
Long term investments | ||||
Property, plant & equipment | $80.79 | $74.57 | ||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $2347.12 | $2309.73 | ||
Current liabilities | ||||
Accounts payable | $6.75 | $9.2 | ||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $587.91 | $566.05 | ||
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $713.43 | $694.11 | ||
Shareholders' equity | ||||
Retained earnings | -$1478.33 | -$1409.15 | ||
Other shareholder equity | $1.15 | -$2.79 | ||
Total shareholder equity |
(in millions $) | 31 Jan 2025 | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $214.32 | $151.49 | $101.5 | |
Inventory | ||||
Total current assets | $1297.33 | $914.73 | $1817.7 | |
Long term investments | ||||
Property, plant & equipment | $67.29 | $62.3 | $48.8 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $2321.41 | $2258.91 | $2042.2 | |
Current liabilities | ||||
Accounts payable | $6.76 | $11.21 | $9.9 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $590.07 | $473.28 | $281.3 | |
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $727.36 | $602.21 | $391.4 | |
Shareholders' equity | ||||
Retained earnings | -$1339.04 | -$1000.35 | -$621.7 | |
Other shareholder equity | -$1.55 | -$6.37 | $0.5 | |
Total shareholder equity |
(in millions $) | 30 Oct 2025 | 30 Jul 2025 | 1 May 2025 | 31 Jan 2025 |
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | ||||
Interest expense | ||||
Net income | ||||
Net income | ||||
Income (for common shares) |
(in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $621.15 | $422.18 | $204.8 | $93.1 |
Cost of revenue | ||||
Gross Profit | $441.87 | $278 | $123.1 | $53.7 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $813.58 | $677.38 | $388.9 | $169.3 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $5.86 | -$5.61 | $1 | $0.5 |
Interest expense | $44.66 | $19.58 | -$0.6 | -$1.2 |
Net income | ||||
Net income | -$338.69 | -$378.68 | -$271.1 | -$117.6 |
Income (for common shares) |
(in millions $) | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 | 1 Dec 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$115.62 | -$106.26 | $140.59 | $27.56 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $21.59 | $6.53 | $47.46 | $23.78 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$49.73 | -$57.73 | $119.68 | -$10.85 |
(in millions $) | 2 Mar 2024 | 3 Mar 2023 | 3 Mar 2022 | 3 Mar 2021 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $140.59 | -$1312.67 | -$19.74 | -$6.27 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $47.46 | $36.31 | $1387.12 | $423.98 |
Effect of exchange rate | $1.15 | $0.29 | ||
Change in cash and equivalents | $119.68 | -$1469.64 | $1272.94 | $351.43 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |